| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
730
|
21,947
|
9,357
|
10,569
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
730
|
21,947
|
9,357
|
10,569
| |
|
Operating Expenses |
|
Research Development | 10,313 | 9,097 | 9,860 | 8,818 |
|
Selling General and Administrative | 3,392 | 4,268 | 3,459 | 3,131 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(12,975)
|
8,582
|
(3,962)
|
(1,380)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 900 | 908 | 884 | 879 |
|
Earnings Before Interest And Taxes | (12,075) | 9,490 | (3,078) | (501) |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (12,075) | 9,490 | (3,078) | (501) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (12,075) | 9,490 | (3,078) | (501) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(12,075)
|
9,490
|
(3,078)
|
(501)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(12,075)
|
9,490
|
(3,078)
|
(501)
|
|